Andrew P Beelen

5PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Panel data analysisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 23, 2024
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial.

Heinz-Josef Lenz, Tianshu Liu, Emerson Y Chen

|Feb 03, 2023
[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant.

Ramsha Iqbal, Maqsood Yaqub, Huseyyin O Bektas

|Nov 08, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

Craig M Goodwin, Andrew M Waters, Jennifer E Klomp

|Sep 22, 2022
Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2.

Shom Goel, Antoinette R Tan, Hope S Rugo

|Jul 16, 2022
Pharmacokinetic Drug-Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer.

Chao Li, Janet K Horton, Mark Sale

Pageof 1

Frequent Collaborators

2 joint publications

Philippe Aftimos

1 joint publications

Shom Goel

1 joint publications

Antoinette R Tan

1 joint publications

Hope S Rugo